1 |
Piver B, Fer M, Vitrac X, Merillon JM, Dreano Y, Berthou F, Lucas D. 2004. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem Pharmacol 68: 773-782.
DOI
|
2 |
Messiad H, Amira-Guebailia H, Houache O. 2013. Reversed phase high performance liquid chromatography used for the physicochemical and thermodynamic characterization of piceatannol/ -cyclodextrin complex. J Chromatogr B 926: 21-27.
DOI
|
3 |
Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S, Aggarwal BB. 2002. Piceatannol inhibits TNF-induced activation and -mediated gene expression through suppression of kinase and p65 phosphorylation. J Immunol 169: 6490-6497.
DOI
|
4 |
Dias SJ, Li K, Rimando AM, Dhar S, Mizuno CS, Penman AD, Levenson AS. 2013. Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts. Prostate 73: 1135-1146.
DOI
|
5 |
Jeong SO, Son Y, Lee JH, Cheong YK, Park SH, Chung HT, Pae HO. 2015. Resveratrol analog piceatannol restores the palmitic acid-induced impairment of insulin signaling and production of endothelial nitric oxide via activation of anti-inflammatory and antioxidative heme oxygenase-1 in human endothelial cells. Mol Med Rep 12: 937-944.
DOI
|
6 |
Uchida-Maruki H, Inagaki H, Ito R, Kurita I, Sai M, Ito T. 2015. Piceatannol lowers the blood glucose level in diabetic mice. Biol Pharm Bull 38: 629-633.
DOI
|
7 |
Piotrowska H, Kucinska M, Murias M. 2012. Biological activity of piceatannol: leaving the shadow of resveratrol. Mutat Res 750: 60-82.
DOI
|
8 |
Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B, Jager W. 2011. Chemopreventive effects of resveratrol and resveratrol derivatives. Ann N Y Acad Sci 1215: 89-95.
DOI
|
9 |
Sanyal A, Naumann J, Hoffmann LS, Chabowska-Kita A, Ehrlund A, Schlitzer A, Arner P, Bluher M, Pfeifer A. 2017. Interplay between obesity-induced inflammation and cGMP signaling in white adipose tissue. Cell Rep 18: 225-236.
DOI
|
10 |
Ertunc ME, Hotamisligil GS. 2016. Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment. J Lipid Res 57: 2099-2114.
DOI
|
11 |
Liu L, Li J, Kundu JK, Surh YJ. 2014. Piceatannol inhibits phorbol ester-induced expression of COX-2 and iNOS in HR-1 hairless mouse skin by blocking the activation of and AP-1. Inflamm Res 63: 1013-1021.
DOI
|
12 |
Yang SJ, Lim Y. 2014. Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. Metabolism 63: 693-701.
DOI
|
13 |
Aval PS, Werner J, Cerqueira A, Balfour-Boehm J, Ulanova M. 2013. Piceatannol modulates lung epithelial cellular responses to Pseudomonas aeruginosa. Inflamm Allergy Drug Targets 12: 297-307.
DOI
|
14 |
Abd-Elgawad H, Abu-Elsaad N, El-Karef A, Ibrahim T. 2016. Piceatannol increases the expression of hepatocyte growth factor and IL-10 thereby protecting hepatocytes in thioacetamide-induced liver fibrosis. Can J Physiol Pharmacol 94: 779-787.
DOI
|
15 |
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
DOI
|
16 |
Kawai T, Akira S. 2007. Signaling to by Toll-like receptors. Trends Mol Med 13: 460-469.
DOI
|
17 |
Arai D, Kataoka R, Otsuka S, Kawamura M, Maruki-Uchida H, Sai M, Ito T, Nakao Y. 2016. Piceatannol is superior to resveratrol in promoting neural stem cell differentiation into astrocytes. Food Funct 7: 4432-4441.
DOI
|
18 |
Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. 1997. Protection from obesity-induced insulin resistance in mice lacking function. Nature 389: 610-614.
DOI
|
19 |
Choi RY, Ham JR, Lee MK. 2016. Esculetin prevents nonalcoholic fatty liver in diabetic mice fed high-fat diet. Chem Biol Interact 260: 13-21.
DOI
|
20 |
Verzola D, Bonanni A, Sofia A, Montecucco F, D'Amato E, Cademartori V, Parodi EL, Viazzi F, Venturelli C, Brunori G, Garibotto G. 2016. Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease. J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12129.
|
21 |
Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesityinduced insulin resistance. Science 271: 665-668.
DOI
|
22 |
Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of . Science 293: 1673-1677.
DOI
|
23 |
Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. 2002. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336.
DOI
|
24 |
Wu H, Wang Y, Wu C, Yang P, Li H, Li Z. 2016. Resveratrol induces cancer cell apoptosis through MiR-326/PKM2-mediated ER stress and mitochondrial fission. J Agric Food Chem 64: 9356-9367.
DOI
|
25 |
Bonnefont-Rousselot D. 2016. Resveratrol and cardiovascular diseases. Nutrients 8: E250.
DOI
|
26 |
Huang H, Chen G, Liao D, Zhu Y, Pu R, Xue X. 2016. The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials. Obes Rev 17: 1329-1340.
DOI
|
27 |
Rege SD, Geetha T, Broderick TL, Babu JR. 2015. Resveratrol protects amyloid-induced oxidative damage and memory associated proteins in H19-7 hippocampal neuronal cells. Curr Alzheimer Res 12: 147-156.
DOI
|
28 |
Zhao HF, Li N, Wang Q, Cheng XJ, Li XM, Liu TT. 2015. Resveratrol decreases the insoluble -42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats. Neuroscience 310: 641-649.
DOI
|
29 |
Wang S, Liang X, Yang Q, Fu X, Zhu M, Rodgers BD, Jiang Q, Dodson MV, Du M. 2016. Resveratrol enhances brown adipocyte formation and function by activating AMP-activated protein kinase (AMPK) in mice fed high-fat diet. Mol Nutr Food Res doi: 10.1002/mnfr.201600746.
|
30 |
Kim S, Jin Y, Choi Y, Park T. 2011. Resveratrol exerts antiobesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol 81: 1343-1351.
DOI
|
31 |
Kita Y, Miura Y, Yagasaki K. 2012. Antiproliferative and anti-invasive effect of piceatannol, a polyphenol present in grapes and wine, against hepatoma AH109A cells. J Biomed Biotechnol 2012: 672416.
|